Common Contracts
2 similar Support Agreement contracts by ARCA Biopharma, Inc.
SUPPORT AGREEMENTSupport Agreement • April 3rd, 2024 • ARCA Biopharma, Inc. • In vitro & in vivo diagnostic substances • Delaware
This Support Agreement (this “Agreement”) is made and entered into as of April 3, 2024, by and among Oruka Therapeutics, Inc., a Delaware corporation (the “Company”), ARCA biopharma, Inc., a Delaware corporation (“Parent”), and the undersigned stockholder (the “Stockholder”) of the Parent. Capitalized terms used herein but not otherwise defined shall have the respective meanings ascribed to such terms in the Merger Agreement (as defined below).
SUPPORT AGREEMENTSupport Agreement • April 3rd, 2024 • ARCA Biopharma, Inc. • In vitro & in vivo diagnostic substances • Delaware
This Support Agreement (this “Agreement”) is made and entered into as of April 3, 2024, by and among Oruka Therapeutics, Inc., a Delaware corporation (the “Company”), ARCA biopharma, Inc., a Delaware corporation (“Parent”), and the undersigned stockholder (the “Stockholder”) of the Company. Capitalized terms used herein but not otherwise defined shall have the respective meanings ascribed to such terms in the Merger Agreement (as defined below).
